GLP-1 SM research explained

GLP-1 SM Research: Structure and Laboratory Studies

Research only. All AVM Labs USA products are sold strictly for laboratory research. Nothing on this page is medical advice, and nothing here describes use in humans or animals.

GLP-1 SM is one of the most searched research peptides in the scientific literature. This guide explains it the way the laboratory literature does: its molecular structure, how it is synthesized and characterized, and how to read the studies that mention it.

What GLP-1 SM is, in laboratory terms

GLP-1 SM is a synthetic peptide studied in the incretin literature. Incretins are a class of peptide hormones first described in metabolic research, and GLP-1 SM is a laboratory analogue built on that framework: a chain of 31 amino acids, designed and produced by solid-phase synthesis rather than isolated from a natural source.

Its sequence shares about 94% homology with the human GLP-1 sequence, with selected residues replaced. In the published literature it is described as an agonist at the GLP-1 receptor in assay systems — a single-receptor classification, which is how research papers identify it, and the reason it is usually discussed alongside the other coded compounds in this family, GLP-2 TZ and GLP-3 RT.

Molecular structure

The reported molecular formula of GLP-1 SM is C187H291N45O59, with an average molecular weight of approximately 4113.58 Da (monoisotopic mass approximately 4111.12 Da). Three structural features define it in the literature:

  • A 31-amino-acid backbone based on the GLP-1 sequence, with selected residues replaced. One of the substitutions uses alpha-aminoisobutyric acid (Aib) at position 8, a non-standard amino acid that changes how the chain folds and how it behaves in solution. A second substitution places arginine at position 34.
  • A fatty diacid side chain (C18) attached through a short linker at lysine 26. Lipidation of this kind is a standard design strategy in peptide research: it changes the molecule’s solubility and its behavior in assay systems.
  • A compact chain for its family. At 31 amino acids, GLP-1 SM is the shortest chain of the three coded compounds in this family, and the smallest by molecular weight — a structural fact that matters on a Certificate of Analysis, where the mass is the first identity check.

These are structural facts, reported in the analytical literature. They are what a Certificate of Analysis verifies: the sequence, the modifications, and the molecular weight.

How it compares to GLP-2 TZ and GLP-3 RT

The three coded compounds in this family are often studied together, and the literature distinguishes them by structure, not by name:

  • GLP-1 SM is built on the GLP-1 sequence framework: 31 amino acids, Aib at position 8, a C18 fatty diacid side chain, and a single-receptor profile in assay systems. Molecular weight approximately 4113.58 Da.
  • GLP-2 TZ is built on the GIP sequence framework: 39 amino acids, Aib substitutions and a C20 fatty diacid side chain, with a dual-receptor profile in assay systems. Molecular weight approximately 4813.5 Da.
  • GLP-3 RT is a triple agonist in the literature, acting at three receptors of the same family, with a different sequence and modification pattern again. Molecular weight approximately 4731.3 Da.

Same family, different sequences, different receptor profiles in assay systems. That is the comparison the literature makes — and the reason the three codes exist as separate entries in a research catalogue.

How research peptides like GLP-1 SM are made: solid-phase synthesis

Like most research peptides, GLP-1 SM is produced by solid-phase peptide synthesis (SPPS):

  1. The first amino acid is anchored to a solid resin support.
  2. Amino acids are added one at a time, in the planned sequence, with the growing chain held on the resin.
  3. Protecting groups shield the parts of each amino acid that should not react yet, and are removed at the right step.
  4. The fatty diacid side chain and linker are attached at the planned lysine residue.
  5. The finished chain is cleaved from the resin and purified.

Because the sequence is built step by step, the laboratory controls exactly which peptide is produced — and can confirm it afterward. Our post on peptide synthesis explains this method in detail.

How GLP-1 SM is characterized: identity and purity

A research peptide is not defined by its code alone. In the laboratory it is defined by analytical data, typically:

  • Mass spectrometry (MS): confirms the molecular weight matches the intended sequence, including the side chain and modifications.
  • High-performance liquid chromatography (HPLC): measures purity and reveals impurities, including deletion sequences or incomplete coupling products from synthesis.
  • Certificate of Analysis (COA): the laboratory document that reports those results for a specific batch.

When comparing research materials, the COA is the document that matters: same code, different batch, different data. AVM Labs USA publishes COAs for its research peptides for this reason. Our guide on how to read a peptide COA explains what each field on that document means.

How GLP-1 SM is studied in the literature

Laboratory research on GLP-1 SM takes several forms:

  • Structural studies: how the chain folds, how the lipid side chain sits against the backbone, and how stable the structure is under different conditions.
  • In vitro receptor assays: measurements of binding and activation at the GLP-1 receptor in cell-based systems, where conditions are controlled and variables are isolated.
  • Analytical studies: stability, solubility and degradation — how the peptide behaves in solution, at different temperatures, and over time.

Each of these answers a different question, and a single study rarely answers all of them. The literature on a widely studied peptide can run to hundreds of papers without settling every question.

Stability and handling in the laboratory

Peptides are sensitive molecules, and laboratory handling reflects that. The topics researchers document include storage temperature, protection from light and moisture, freeze–thaw cycles, and how long a prepared solution remains stable. Our posts on peptide storage and stability and on refrigeration and shipping cover this in detail, because it is one of the most practical questions in peptide research.

How to read a GLP-1 SM study

When you open a paper that mentions GLP-1 SM, check four things first:

  1. What exactly was studied? The code, the sequence or identifier, and the source of the material.
  2. In what model? In vitro assay, animal model, or another setting — and what that model can and cannot show.
  3. At what scale? The number of samples, the controls used, and whether the result was reproduced.
  4. Who funded it, and where was it published? Peer review and disclosure are part of the evidence, not decoration.

A study that is careful about those four points is worth more than a dramatic headline about one that is not. For the general background, start with What Are Peptides?

Related research on this blog

Glossary

  • Incretin: a class of peptide hormones first described in metabolic research; the framework GLP-1 SM is built on.
  • Receptor agonist: in assay systems, a molecule that activates a specific receptor.
  • Homology: the degree to which two sequences share the same amino acids in the same positions.
  • Aib (alpha-aminoisobutyric acid): a non-standard amino acid used as a substitution in synthetic peptide design.
  • Lipidation: attaching a fatty acid chain to a peptide, a standard design strategy in peptide research.
  • SPPS: solid-phase peptide synthesis, the standard laboratory method for building peptides.
  • HPLC: high-performance liquid chromatography, used to measure purity.
  • Mass spectrometry (MS): used to confirm molecular weight and identity.
  • COA: Certificate of Analysis, the batch document reporting analytical results.
  • In vitro: experiments outside a living organism, e.g. in cell culture.

Frequently asked questions (research framing)

What does GLP-1 SM stand for? — Answer: It is the laboratory code used in this catalogue for a 31-amino-acid synthetic peptide studied in the incretin literature.

How is GLP-1 SM different from GLP-2 TZ? — Answer: They are built on different sequence frameworks — GLP-1 SM on the GLP-1 framework, GLP-2 TZ on the GIP framework — with different chain lengths, different substitutions and different receptor profiles in assay systems.

What does a COA tell me? — Answer: It reports the analytical results — identity and purity — for one specific batch, measured by the laboratory that tested it.

Where can I learn more? — Answer: Start with the posts linked above, and read the primary literature they cite. For storage and handling, see our posts on peptide stability and refrigeration.

Research only. AVM Labs USA products are for laboratory research use only.

Scroll to Top
header ´para el telefono

Welcome back to AVM Labs USA. Sign in below to access your account and continue shopping.

Don’t have an account yet?
Create your AVM Labs USA account before signing in.